Dr Richard Kelwick is a senior research associate and former Royal Society of Edinburgh Enterprise Fellow with research interests in synthetic biology, cell-free gene expression systems and extracellular vesicle biology.
Dr Kelwick has a Ph.D. in cancer biology in which he researched the roles of metalloproteinases in cancer. Specifically, investigating the protective mechanisms of A Disintegrin and Metalloproteinase with Thrombospondin motifs 15 (ADAMTS-15) in breast cancer. Dr Kelwick joined Prof. Paul Freemont’s group in 2013 where he has developed expertise in synthetic biology including the development of biosensors, biological materials and cell-free gene expression systems. Most recently Dr Kelwick is applying his expertise in synthetic biology towards the development of novel extracellular vesicle (EV) biosensors, engineering and isolation methods for industrial applications.
